Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1109
-0.0078 (-6.57%)
At close: Jul 24, 2026, 4:00 PM EDT
0.1075
-0.0034 (-3.07%)
After-hours: Jul 24, 2026, 7:59 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $4.98 million as of July 24, 2026. Its market cap has decreased by -97.04% in one year.
Market Cap
4.98M
Enterprise Value
4.51M
1-Year Change
-97.04%
Ranking
Category
Stock Price
$0.11
ChartMarket Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $4.98M, a decrease of -98.56%. That is a compound annual growth rate of -56.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 4.98M | -69.85% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 5.78M |
| Adial Pharmaceuticals | 5.77M |
| Curanex Pharmaceuticals | 5.76M |
| Aptevo Therapeutics | 5.68M |
| NuCana | 5.56M |
| Soligenix | 5.47M |
| AIM ImmunoTech | 5.38M |
| Dermata Therapeutics | 5.13M |